Microneedle Flu Vaccine Market
1 Study Coverage
1.1 Microneedle Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Market by Application
1.3.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Microneedle Flu Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Microneedle Flu Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Microneedle Flu Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Microneedle Flu Vaccine Sales by Region
2.4.1 Global Microneedle Flu Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Microneedle Flu Vaccine by Region (2023-2028)
2.5 Global Microneedle Flu Vaccine Revenue by Region
2.5.1 Global Microneedle Flu Vaccine Revenue by Region (2017-2022)
2.5.2 Global Microneedle Flu Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Microneedle Flu Vaccine Sales by Manufacturers
3.1.1 Global Top Microneedle Flu Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microneedle Flu Vaccine in 2021
3.2 Global Microneedle Flu Vaccine Revenue by Manufacturers
3.2.1 Global Microneedle Flu Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Microneedle Flu Vaccine Revenue in 2021
3.3 Global Microneedle Flu Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Microneedle Flu Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microneedle Flu Vaccine Sales by Type
4.1.1 Global Microneedle Flu Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Microneedle Flu Vaccine Revenue by Type
4.2.1 Global Microneedle Flu Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Microneedle Flu Vaccine Price by Type
4.3.1 Global Microneedle Flu Vaccine Price by Type (2017-2022)
4.3.2 Global Microneedle Flu Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Microneedle Flu Vaccine Sales by Application
5.1.1 Global Microneedle Flu Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Microneedle Flu Vaccine Revenue by Application
5.2.1 Global Microneedle Flu Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Microneedle Flu Vaccine Price by Application
5.3.1 Global Microneedle Flu Vaccine Price by Application (2017-2022)
5.3.2 Global Microneedle Flu Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Microneedle Flu Vaccine Market Size by Type
6.1.1 North America Microneedle Flu Vaccine Sales by Type (2017-2028)
6.1.2 North America Microneedle Flu Vaccine Revenue by Type (2017-2028)
6.2 North America Microneedle Flu Vaccine Market Size by Application
6.2.1 North America Microneedle Flu Vaccine Sales by Application (2017-2028)
6.2.2 North America Microneedle Flu Vaccine Revenue by Application (2017-2028)
6.3 North America Microneedle Flu Vaccine Market Size by Country
6.3.1 North America Microneedle Flu Vaccine Sales by Country (2017-2028)
6.3.2 North America Microneedle Flu Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Microneedle Flu Vaccine Market Size by Type
7.1.1 Europe Microneedle Flu Vaccine Sales by Type (2017-2028)
7.1.2 Europe Microneedle Flu Vaccine Revenue by Type (2017-2028)
7.2 Europe Microneedle Flu Vaccine Market Size by Application
7.2.1 Europe Microneedle Flu Vaccine Sales by Application (2017-2028)
7.2.2 Europe Microneedle Flu Vaccine Revenue by Application (2017-2028)
7.3 Europe Microneedle Flu Vaccine Market Size by Country
7.3.1 Europe Microneedle Flu Vaccine Sales by Country (2017-2028)
7.3.2 Europe Microneedle Flu Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Microneedle Flu Vaccine Market Size by Type
8.1.1 Asia Pacific Microneedle Flu Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Microneedle Flu Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Microneedle Flu Vaccine Market Size by Application
8.2.1 Asia Pacific Microneedle Flu Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Microneedle Flu Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Microneedle Flu Vaccine Market Size by Region
8.3.1 Asia Pacific Microneedle Flu Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Microneedle Flu Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Microneedle Flu Vaccine Market Size by Type
9.1.1 Latin America Microneedle Flu Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Microneedle Flu Vaccine Revenue by Type (2017-2028)
9.2 Latin America Microneedle Flu Vaccine Market Size by Application
9.2.1 Latin America Microneedle Flu Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Microneedle Flu Vaccine Revenue by Application (2017-2028)
9.3 Latin America Microneedle Flu Vaccine Market Size by Country
9.3.1 Latin America Microneedle Flu Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Microneedle Flu Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Microneedle Flu Vaccine Market Size by Type
10.1.1 Middle East and Africa Microneedle Flu Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Microneedle Flu Vaccine Market Size by Application
10.2.1 Middle East and Africa Microneedle Flu Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Microneedle Flu Vaccine Market Size by Country
10.3.1 Middle East and Africa Microneedle Flu Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GC Pharma
11.2.1 GC Pharma Corporation Information
11.2.2 GC Pharma Overview
11.2.3 GC Pharma Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GC Pharma Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GC Pharma Recent Developments
11.3 Debiotech
11.3.1 Debiotech Corporation Information
11.3.2 Debiotech Overview
11.3.3 Debiotech Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Debiotech Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Debiotech Recent Developments
11.4 NanoPass Technologies
11.4.1 NanoPass Technologies Corporation Information
11.4.2 NanoPass Technologies Overview
11.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 NanoPass Technologies Recent Developments
11.5 Corium International
11.5.1 Corium International Corporation Information
11.5.2 Corium International Overview
11.5.3 Corium International Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Corium International Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Corium International Recent Developments
11.6 Becton Dickinson and Company
11.6.1 Becton Dickinson and Company Corporation Information
11.6.2 Becton Dickinson and Company Overview
11.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Becton Dickinson and Company Recent Developments
11.7 FluGen
11.7.1 FluGen Corporation Information
11.7.2 FluGen Overview
11.7.3 FluGen Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 FluGen Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 FluGen Recent Developments
11.8 CosMED Pharmaceuticals
11.8.1 CosMED Pharmaceuticals Corporation Information
11.8.2 CosMED Pharmaceuticals Overview
11.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CosMED Pharmaceuticals Recent Developments
11.9 Microdermics and OraSure Technologies
11.9.1 Microdermics and OraSure Technologies Corporation Information
11.9.2 Microdermics and OraSure Technologies Overview
11.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Microdermics and OraSure Technologies Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microneedle Flu Vaccine Industry Chain Analysis
12.2 Microneedle Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microneedle Flu Vaccine Production Mode & Process
12.4 Microneedle Flu Vaccine Sales and Marketing
12.4.1 Microneedle Flu Vaccine Sales Channels
12.4.2 Microneedle Flu Vaccine Distributors
12.5 Microneedle Flu Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Microneedle Flu Vaccine Industry Trends
13.2 Microneedle Flu Vaccine Market Drivers
13.3 Microneedle Flu Vaccine Market Challenges
13.4 Microneedle Flu Vaccine Market Restraints
14 Key Findings in The Global Microneedle Flu Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Solid Microneedle
Table 3. Major Manufacturers of Hollow Microneedle
Table 4. Major Manufacturers of Coated Microneedle
Table 5. Major Manufacturers of Dissolving Microneedle
Table 6. Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Microneedle Flu Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Microneedle Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 9. Global Microneedle Flu Vaccine Sales Market Share by Region (2017-2022)
Table 10. Global Microneedle Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 11. Global Microneedle Flu Vaccine Sales Market Share by Region (2023-2028)
Table 12. Global Microneedle Flu Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Microneedle Flu Vaccine Revenue Market Share by Region (2017-2022)
Table 14. Global Microneedle Flu Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Microneedle Flu Vaccine Revenue Market Share by Region (2023-2028)
Table 16. Global Microneedle Flu Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Microneedle Flu Vaccine Sales Share by Manufacturers (2017-2022)
Table 18. Global Microneedle Flu Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2017-2022)
Table 20. Microneedle Flu Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Microneedle Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2021)
Table 23. Microneedle Flu Vaccine Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Microneedle Flu Vaccine Product Offered
Table 25. Date of Manufacturers Enter into Microneedle Flu Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 28. Global Microneedle Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 29. Global Microneedle Flu Vaccine Sales Share by Type (2017-2022)
Table 30. Global Microneedle Flu Vaccine Sales Share by Type (2023-2028)
Table 31. Global Microneedle Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Microneedle Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Microneedle Flu Vaccine Revenue Share by Type (2017-2022)
Table 34. Global Microneedle Flu Vaccine Revenue Share by Type (2023-2028)
Table 35. Microneedle Flu Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Microneedle Flu Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 38. Global Microneedle Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 39. Global Microneedle Flu Vaccine Sales Share by Application (2017-2022)
Table 40. Global Microneedle Flu Vaccine Sales Share by Application (2023-2028)
Table 41. Global Microneedle Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Microneedle Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Microneedle Flu Vaccine Revenue Share by Application (2017-2022)
Table 44. Global Microneedle Flu Vaccine Revenue Share by Application (2023-2028)
Table 45. Microneedle Flu Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Microneedle Flu Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 48. North America Microneedle Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 49. North America Microneedle Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Microneedle Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 52. North America Microneedle Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 53. North America Microneedle Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Microneedle Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 56. North America Microneedle Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 57. North America Microneedle Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Microneedle Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 60. Europe Microneedle Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 61. Europe Microneedle Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Microneedle Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Europe Microneedle Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 65. Europe Microneedle Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Microneedle Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 68. Europe Microneedle Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 69. Europe Microneedle Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Microneedle Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Microneedle Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Microneedle Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Microneedle Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Microneedle Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Microneedle Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Microneedle Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Microneedle Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Microneedle Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Microneedle Flu Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Microneedle Flu Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Microneedle Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Microneedle Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Microneedle Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Microneedle Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Microneedle Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Microneedle Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Microneedle Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Microneedle Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Microneedle Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Microneedle Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Microneedle Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Microneedle Flu Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Microneedle Flu Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Microneedle Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Microneedle Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Microneedle Flu Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Microneedle Flu Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Microneedle Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Microneedle Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 107. Sanofi Corporation Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Sanofi Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. GC Pharma Corporation Information
Table 113. GC Pharma Description and Major Businesses
Table 114. GC Pharma Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. GC Pharma Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GC Pharma Recent Developments
Table 117. Debiotech Corporation Information
Table 118. Debiotech Description and Major Businesses
Table 119. Debiotech Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Debiotech Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Debiotech Recent Developments
Table 122. NanoPass Technologies Corporation Information
Table 123. NanoPass Technologies Description and Major Businesses
Table 124. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. NanoPass Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. NanoPass Technologies Recent Developments
Table 127. Corium International Corporation Information
Table 128. Corium International Description and Major Businesses
Table 129. Corium International Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Corium International Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Corium International Recent Developments
Table 132. Becton Dickinson and Company Corporation Information
Table 133. Becton Dickinson and Company Description and Major Businesses
Table 134. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Becton Dickinson and Company Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Becton Dickinson and Company Recent Developments
Table 137. FluGen Corporation Information
Table 138. FluGen Description and Major Businesses
Table 139. FluGen Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. FluGen Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. FluGen Recent Developments
Table 142. CosMED Pharmaceuticals Corporation Information
Table 143. CosMED Pharmaceuticals Description and Major Businesses
Table 144. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CosMED Pharmaceuticals Recent Developments
Table 147. Microdermics and OraSure Technologies Corporation Information
Table 148. Microdermics and OraSure Technologies Description and Major Businesses
Table 149. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Microdermics and OraSure Technologies Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Microneedle Flu Vaccine Distributors List
Table 155. Microneedle Flu Vaccine Customers List
Table 156. Microneedle Flu Vaccine Market Trends
Table 157. Microneedle Flu Vaccine Market Drivers
Table 158. Microneedle Flu Vaccine Market Challenges
Table 159. Microneedle Flu Vaccine Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Microneedle Flu Vaccine Product Picture
Figure 3. Global Microneedle Flu Vaccine Market Share by Type in 2021 & 2028
Figure 3. Solid Microneedle Product Picture
Figure 4. Hollow Microneedle Product Picture
Figure 5. Coated Microneedle Product Picture
Figure 6. Dissolving Microneedle Product Picture
Figure 7. Global Microneedle Flu Vaccine Market Share by Application in 2021 & 2028
Figure 8. Influenza A
Figure 9. Influenza B
Figure 10. Microneedle Flu Vaccine Report Years Considered
Figure 11. Global Microneedle Flu Vaccine Sales 2017-2028 (K Units)
Figure 12. Global Microneedle Flu Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Microneedle Flu Vaccine Revenue 2017-2028 (US$ Million)
Figure 14. Global Microneedle Flu Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Microneedle Flu Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Microneedle Flu Vaccine Sales Market Share by Region (2023-2028)
Figure 17. North America Microneedle Flu Vaccine Sales YoY (2017-2028) & (K Units)
Figure 18. North America Microneedle Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Microneedle Flu Vaccine Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Microneedle Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Microneedle Flu Vaccine Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Microneedle Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Microneedle Flu Vaccine Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Microneedle Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Microneedle Flu Vaccine Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Microneedle Flu Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Microneedle Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Microneedle Flu Vaccine in the World: Market Share by Microneedle Flu Vaccine Revenue in 2021
Figure 29. Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. North America Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 35. North America Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. North America Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. North America Microneedle Flu Vaccine Sales Share by Country (2017-2028)
Figure 39. North America Microneedle Flu Vaccine Revenue Share by Country (2017-2028)
Figure 40. U.S. Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 44. Europe Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 46. Europe Microneedle Flu Vaccine Sales Share by Country (2017-2028)
Figure 47. Europe Microneedle Flu Vaccine Revenue Share by Country (2017-2028)
Figure 48. Germany Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. France Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Microneedle Flu Vaccine Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Microneedle Flu Vaccine Revenue Share by Region (2017-2028)
Figure 59. China Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. India Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Latin America Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 72. Latin America Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Microneedle Flu Vaccine Sales Share by Country (2017-2028)
Figure 74. Latin America Microneedle Flu Vaccine Revenue Share by Country (2017-2028)
Figure 75. Mexico Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Microneedle Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Microneedle Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Microneedle Flu Vaccine Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Microneedle Flu Vaccine Revenue Share by Country (2017-2028)
Figure 84. Turkey Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Microneedle Flu Vaccine Revenue (2017-2028) & (US$ Million)
Figure 87. Microneedle Flu Vaccine Value Chain
Figure 88. Microneedle Flu Vaccine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Industry Market Size
